NTRA News and Press, Natera Inc. From 07/29/21

Natera Announces Second Quarter 2021 Earnings Conference Call PR Newswire AUSTIN, Texas , July 29, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its sec...

New Study Validates the Signatera® MRD Test and Demonstrates its Clinical Utility in Early-Stage Esophageal Cancer 14th peer-reviewed Signatera paper with over 3,000 patients studied PR Newswire AUSTIN, Texas , July 28, 2021 /PRNewswire/ -- Natera,Inc....

New Publication Shows 96% Overall Survival Among Metastatic Colorectal Cancer Patients Who Test MRD-Negative with Signatera® After Surgery Data will be used to support submission to CMS for reimbursement, expanding Signatera's coverage beyond early-stage colorectal cancer ...

BlackJack3D/E+ via Getty Images Natera (NTRA) has priced its public offering of 4.5M shares of its common stock at $113.00/share. Underwriters' over-allotment is an additional 675K shares. Closing date is July 26. Morgan Stanley, Goldman Sachs, Cowen and SVB Leerink are acting as joint book-r...

Genetic test maker Natera has launched a follow-on public offering of $350M common shares.The company expects to grant a 30-day option for underwriters to buy another $52.5M of shares at the offer price. The pricing and other terms of the offering remain undisclosed.Natera expects its Q221 re...

Rasi Bhadramani/iStock via Getty Images After more than doubling in value over the past 12-month period, Natera ([[NTRA]] -6.3%) has lost more than a tenth of value today, recording its biggest one-day loss since mid-May. Announcing the preliminary Q2 2021 results on Monday, Natera said that ...

Natera's (NTRA) revenue and volume growth rate in Q2 2021 was the largest Y/Y growth in its history as a publicly traded company.Total revenues for the Q2 of 2021 are expected to be ~$138-$141M vs. consensus of $127.48M, which represents ~60% Y/Y growth.The Co. expects its product revenu...

Natera Reports Preliminary Second Quarter 2021 Results Record Growth in Revenues and Tests Processed; Women's Health Business Cash Flow Breakeven PR Newswire AUSTIN, Texas , July 19, 2021 /PRNewswire/ -- Natera, Inc. (Nasdaq: NTRA) ("Natera" or the "Comp...

SusanneB/E+ via Getty Images As the third quarter gets underway, BTIG has issued its list of top large-cap stock picks. The picks are the highest-conviction stocks over a 12-month time horizon starting H2 2021. Among sectors, BTIG is overweight three areas: Energy (XLE), Financials (XLF) and ...

New Results From the Landmark Prospective CIRCULATE Trial Expand Clinical Utility of the Signatera® MRD Test in Colorectal Cancer Data presented in oral session at the 2021 ESMO GI Congress shows >99% of MRD-negative patients were recurrence-free at 6 months of follow-up...